Showing results (1-10 of 168) with videos related to
Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|June 9, 2020
Epithelial barriers in allergy and asthmaPeter W Hellings, Brecht SteelantClinical and Translational Allergy|September 15, 2018
Calu-3 epithelial cells exhibit different immune and epithelial barrier responses from freshly isolated primary nasal epithelial cells in vitroKatleen Martens, Peter W Hellings, Brecht SteelantFrontiers in Allergy|May 1, 2023
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?Dorien Van Broeck, Brecht Steelant, Glenis Scadding, et al.Current Allergy and Asthma Reports|March 19, 2021
A TRiP Through the Roles of Transient Receptor Potential Cation Channels in Type 2 Upper Airway InflammationWout Backaert, Brecht Steelant, Peter W Hellings, et al.Immunology and Allergy Clinics of North America|April 11, 2018
Exercise and Sinonasal DiseaseBrecht Steelant, Valerie Hox, Peter W Hellings, et al.Clinical and Translational Allergy|July 15, 2017
Endotype-driven treatment in chronic upper airway diseasesGlynnis De Greve, Peter W Hellings, Wytske J Fokkens, et al.The Journal of Allergy and Clinical Immunology|May 5, 2024
The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitisEmma Ruysseveldt, Brecht Steelant, Tine Wils, et al.Current Opinion in Pulmonary Medicine|November 6, 2019
Epithelial dysfunction in chronic respiratory diseases, a shared endotype?Brecht SteelantThe World Allergy Organization Journal|September 27, 2021
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitisMaria Doulaptsi, Tine Wils, Peter W Hellings, et al.American Journal of Rhinology & Allergy|September 9, 2014
Nasal allergen deposition leads to conjunctival mast cell degranulation in allergic rhinoconjunctivitisIna Callebaut, Annick De Vries, Brecht Steelant, et al.Pageof 17